4//SEC Filing
Kunin Audrey 4
Accession 0001437749-21-027397
CIK 0001389545other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:46 PM ET
Size
6.6 KB
Accession
0001437749-21-027397
Insider Transaction Report
Form 4
Kunin Audrey
Chief Product Officer
Transactions
- Purchase
Common Stock
2021-11-22$0.46/sh+25,000$11,500→ 25,000 total(indirect: see footnote) - Purchase
Common Stock
2021-11-23$0.46/sh+66,133$30,368→ 91,133 total(indirect: see footnote)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $0.4545 to $0.4610. The price reported above reflected the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001738781
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 4:46 PM ET
- Size
- 6.6 KB